Sinex%252520%252528oxymetazoline%252529

# Sinex (oxymetazoline) ## Overview Oxymetazoline is an imidazoline derivative with direct-acting sympathomimetic activity. It is a topical nasal decongestant that produces vasoconstriction of nasal blood vessels via alpha-adrenergic receptor agonism, reducing nasal congestion. ## Primary Indications - Symptomatic relief of nasal congestion associated with the common cold, sinusitis, allergic rhinitis, and other upper respiratory tract conditions. ## Adult Dosing - **Intranasal (0.05% solution):** 2–3 sprays per nostril every 10–12 hours. - **Maximum:** Do not exceed 2 doses in 24 hours. Duration of use should not exceed 3 days to avoid rebound congestion (rhinitis medicamentosa). ## Pediatric Dosing - **Children 6–12 years:** 1 spray per nostril every 10–12 hours. Maximum 2 doses in 24 hours. - **Children 2–5 years:** 1 spray per nostril every 10–12 hours. Maximum 2 doses in 24 hours. Use only under adult supervision. - **Children <2 years:** Not recommended due to risk of serious adverse effects (e.g., CNS depression, seizures). Safety and efficacy not established. ## Dose Adjustments - **Renal impairment:** No specific dose adjustment required; systemic absorption is minimal. - **Hepatic impairment:** No specific dose adjustment required. - **Elderly:** Use with caution; may be more sensitive to adverse effects (e.g., hypertension, dizziness). ## Contraindications - Hypersensitivity to oxymetazoline or any component of the formulation. - Narrow-angle glaucoma. - Concurrent use of MAO inhibitors (MAOIs) or within 14 days of MAOI therapy (risk of hypertensive crisis). - Transsphenoidal hypophysectomy (risk of intracranial infection). ## Adverse Effects - **Common:** Nasal dryness, burning, stinging, sneezing, transient increase in nasal discharge. - **Serious (rare):** Rebound congestion (rhinitis medicamentosa) with prolonged use (>3 days); hypertension, palpitations, tachycardia; CNS effects (headache, dizziness, insomnia); severe allergic reactions (angioedema, bronchospasm). ## Key Drug Interactions - **MAOIs (e.g., phenelzine, tranylcypromine):** Concurrent use or within 14 days may precipitate hypertensive crisis. Contraindicated. - **Tricyclic antidepressants (e.g., amitriptyline):** May potentiate pressor effects; use with caution. - **Other sympathomimetics (e.g., pseudoephedrine):** Additive cardiovascular effects; avoid concurrent use. ## Monitoring - Monitor for signs of systemic absorption (e.g., hypertension, tachycardia, palpitations), especially in patients with cardiovascular disease. - Assess for rebound congestion if used >3 days. - In pediatric patients, monitor for CNS effects (e.g., sedation, excitability). ## Clinical Pearls - **Duration limit:** Do not use for more than 3 consecutive days to prevent rebound congestion. - **Administration:** Blow nose gently before use. Tilt head forward, insert nozzle, spray while breathing in. Avoid touching nozzle to nasal mucosa. - **Pregnancy:** Category C; use only if clearly needed and benefit outweighs risk. - **Lactation:** Excretion in breast milk unknown; use with caution. - **Overdose:** Systemic effects (hypertension, bradycardia, CNS depression) are rare but possible, especially in children. Treat symptomatically. *Disclaimer: This information is for educational purposes only and does not replace professional clinical judgment. Always verify current prescribing information, local protocols, and individual patient factors before making therapeutic decisions.*